Inflated type I error: Not nice [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2020-11-26 18:14 (1436 d 15:24 ago) – Posting: # 22088
Views: 7,702

Dear Detlew,

❝ ❝ Shit.


❝ Why shit?


Cause it slipped through my attention for almost fifteen years… In South Africa for Cmax fixed limits of 75.00–133.33% may be used (no replicate design needed).

❝ ❝ ❝ Quick and dirty captured code from power.scABEL.sds.

❝ ❝

❝ ❝ How, did you do that? That’s beyond me.


❝ Stolen the code of subject data sims and scaled ABE evaluation in the working horse function .pwr.SABE.sds().

❝ Have a look into the code of the new but undocumented function power.fwl.sds() in the GitHub repository.


THX!

❝ ❝ ...And got 20.568% after eleven (!) hours.

❝ Wow! 11 hours for one number! 106 sims in ca. 4-5 sec with my implementation.


Mühsam ernährt sich das Eichhörnchen.

❝ Some results with setseed=FALSE:

power.fwl.sds(CV=0.3, n=40, theta0=0.8, design="2x2x4", setseed=F)

❝ 0.2045, 0.2066, 0.2047, 0.2051, 0.2082

❝ Seems we are simulating the same number :cool:.


:-D

Terrible for drugs which are not highly variable (reminds me on the FDA’s RSABE). The design is less important.

[image] 2-sequence 4-period (full) replicates

[image] 2-sequence 3-period (full) replicates

[image] 3-sequence 3-period (partial) replicates


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,279 posts in 4,889 threads, 1,657 registered users;
64 visitors (0 registered, 64 guests [including 12 identified bots]).
Forum time: 09:39 CET (Europe/Vienna)

Pharmacokinetics: one of the magic arts of divination
whereby needles are stuck into dummies in an attempt
to predict profits.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5